text:
MyChart Login
Home > Health & Wellness > Health Library > Childhood Ependymoma Treatment (PDQ®): Treatment - Health Professional Information [NCI]
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.
The PDQ childhood brain tumor treatment summaries are organized primarily according to the World Health Organization (WHO) classification of nervous system tumors.[1,2] For a full description of the classification of nervous system tumors and a link to the corresponding treatment summary for each type of brain tumor, refer to the PDQ summary on Childhood Brain and Spinal Cord Tumors Treatment Overview.
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2010, childhood cancer mortality decreased by more than 50%.[3] Childhood and adolescent cancer survivors require close follow-up because cancer therapy side effects may persist or develop months or years after treatment. (Refer to the PDQ summary Late Effects of Treatment for Childhood Cancer for specific information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors.)
Primary brain tumors are a diverse group of diseases that together constitute the most common solid tumor of childhood. Immunohistochemical analysis, cytogenetic and molecular genetic findings, and measures of mitotic activity are increasingly used in tumor diagnosis and classification. Brain tumors are classified according to histology, but tumor location and extent of spread are important factors that affect treatment and prognosis.
Ependymomas arise from ependymal cells that line the ventricles and passageways in the brain and the center of the spinal cord. Ependymal cells produce cerebrospinal fluid (CSF). These tumors are classified as supratentorial or infratentorial. In children, most ependymomas are infratentorial tumors that arise in or around the fourth ventricle. According to the WHO classification of brain tumors, ependymal tumors are classified into the following four main subtypes:
The location of the tumor determines the clinical presentation. Treatment begins with surgery. The type of adjuvant therapy given, such as a second surgery, chemotherapy, or radiation therapy, depends on the following:
Childhood ependymoma comprises approximately 9% of all childhood brain tumors, representing about 200 cases per year in the United States.[4,5]
Anatomy of the inside of the brain, showing the pineal and pituitary glands, optic nerve, ventricles (with cerebrospinal fluid shown in blue), and other parts of the brain. The tentorium separates the cerebrum from the cerebellum. The infratentorium (posterior fossa) is the region below the tentorium that contains the brain stem, cerebellum, and fourth ventricle. The supratentorium is the region above the tentorium and denotes the region that contains the cerebrum.
Clinical Features
The clinical presentation of ependymoma is dependent on tumor location.
Diagnostic Evaluation
Every patient suspected of having ependymoma should be evaluated with diagnostic imaging of the whole brain and spinal cord. The most sensitive method available for evaluating spinal cord subarachnoid metastasis is spinal magnetic resonance imaging (MRI) performed with gadolinium. This is ideally done before surgery to avoid confusion with postoperative blood. If MRI is used, the entire spine is generally imaged in at least two planes with contiguous MRI slices performed after gadolinium enhancement. If feasible, CSF cytological evaluation should be conducted.[7]
Prognostic Factors
Unfavorable factors affecting outcome (except as noted) include the following:
Posterior fossa ependymoma can be divided into the following two groups based on distinctive patterns of gene expression.[12,13]
Other factors that have been reported to be associated with poor prognosis for pediatric ependymoma include expression of the enzymatic subunit of telomerase (hTERT) [15,16,17] and expression of the neural stem cell marker Nestin.[18][Level of evidence: 3iiiA]
Follow-up After Treatment
Surveillance neuroimaging, coupled with clinical assessments, are generally recommended after treatment for ependymoma. The frequency and duration have been arbitrarily determined and the utility is uncertain.[31] Most practitioners obtain MRI imaging of the brain and/or spinal cord every 3 months for the first 1 to 2 years after treatment. After 2 years, imaging every 6 months for the next 3 years is often undertaken.
In the most recent World Health Organization (WHO) classification of brain tumors, ependymal tumors are classified into the following four main subtypes:[1]
The true incidence of subependymomas (WHO Grade I) is difficult to determine. These tumors are frequently asymptomatic and may be found incidentally at autopsy. Subependymomas probably comprise less than 5% of all ependymal tumors.
In children, approximately 65% to 75% of ependymomas arise in the posterior fossa. Although supratentorial and infratentorial ependymomas are believed to arise from radial glia cells, they have different genomic, gene expression, and immunohistochemical signatures.[2,3,4] Supratentorial tumors are more often characterized by neuronal differentiation.[3]
Subependymomas and myxopapillary ependymomas are usually considered to be clinically and pathologically distinct from the Grade II and Grade III ependymomas. In Grade II and Grade III ependymomas, the relationship between histological features and survival has varied among studies, although most recent larger studies and meta-analyses have demonstrated that histological grade is an independent predictor of event-free survival.[5,6,7] A single-institution study suggests that patients with clear-cell ependymomas may have a higher risk of treatment failure than do patients with other forms of WHO Grade II ependymomas;[8] however, confirmation is required in a larger group of unselected patients.
Ependymoblastomas, which generally behave more like medulloblastomas or cerebral neuroectodermal tumors, are considered separate entities from ependymomas and are now classified with the embryonal tumors.[1,5] (Refer to the PDQ summary on Childhood Central Nervous System Embryonal Tumors Treatment for more information.)
The pathologic classification of pediatric brain tumors is a specialized area that is evolving; review of the diagnostic tissue by a neuropathologist who has particular expertise in this area is strongly recommended.
Although there is no formal staging system, ependymomas can be divided into supratentorial, infratentorial, and spinal tumors. Approximately 30% of childhood ependymomas arise in supratentorial regions of the brain and 70% arise in the posterior fossa.[1] They usually originate in the ependymal linings of ventricles or central canal or ventriculus terminalis of the spinal cord and have access to the cerebrospinal fluid. Therefore, these tumors may spread throughout the neuraxis, although dissemination is noted in less than 10% of patients with Grade II and Grade III ependymomas. Myxopapillary ependymomas are more likely to disseminate to the nervous system early in the course of illness.
Many of the improvements in survival in childhood cancer have been made as a result of clinical trials that have attempted to improve on the best available, accepted therapy. Clinical trials in pediatrics are designed to compare new therapy with therapy that is currently accepted as standard. This comparison may be done in a randomized study of two treatment arms or by evaluating a single new treatment and comparing the results with those previously obtained with existing therapy.
Because of the relative rarity of cancer in children, all patients with aggressive brain tumors should be considered for entry into a clinical trial. To determine and implement optimum treatment, treatment planning by a multidisciplinary team of cancer specialists who have experience treating childhood brain tumors is required. Radiation therapy of pediatric brain tumors is technically demanding and should be performed in centers that have experience in that area to ensure optimal results.
The standard treatment options for newly diagnosed subependymoma (WHO Grade I) include the following:
In cases requiring therapy, complete surgical removal is often curative. Some subependymomas are considered incidental findings and observed without intervention.
Occasionally, subependymomas cause ventricular obstruction and, in these cases, ventriculoperitoneal shunt placement is indicated. Spontaneous intratumoral hemorrhage has also been observed.[1]
Myxopapillary ependymomas, considered to be a histologic subtype of ependymoma, have a relatively high incidence of central nervous system tumor dissemination at diagnosis and at follow-up. Imaging of the complete craniospinal axis at the time of diagnosis and during follow-up is indicated.[1,2]
Standard treatment options for newly diagnosed myxopapillary ependymoma (WHO Grade I) include the following:
Historically, the management of myxopapillary ependymoma (WHO Grade I) consisted of an attempt at en bloc resection of the tumor with no further treatment in the case of a gross-total resection.[3]; [4][Level of evidence: 3iiiDi] However, based on the finding that dissemination of these tumors to other parts of the neuraxis can occur, particularly when complete resection is not obtained, and evidence that focal radiation therapy may improve progression-free survival, many practitioners now favor the use of radiation therapy after surgical resection of the primary mass.[1,3]; [5][Level of evidence: 3iiiDi]; [6,7][Level of evidence: 3iiiDiii]
Standard treatment options for newly diagnosed ependymoma (WHO Grade II) or anaplastic ependymoma (WHO Grade III) include the following:
Typically, all patients undergo surgery to remove the tumor. Whether additional treatment is given depends on the extent of tumor resection and whether there is disseminated disease.
Surgery should be performed in an attempt at maximal tumor reduction. Evidence suggests that more extensive surgical resection is related to an improved rate of survival.[1,2,3,4,5]; [6][Level of evidence: 3iDii] Magnetic resonance imaging (MRI) should be performed postoperatively to confirm the extent of resection. If not performed preoperatively, MRI of the entire neuraxis to evaluate disease dissemination and cerebrospinal fluid cytopathology should be performed.
Patients with residual tumor or disseminated disease should be considered at high risk for relapse and should be treated on protocols specifically designed for them. Those with no evidence of residual tumor still have an approximate 20% to 40% relapse risk in spite of postoperative radiation therapy.
Anecdotal experience suggests that surgery alone for completely resected supratentorial nonanaplastic tumors and intradural spinal cord ependymomas may, in select cases, be an appropriate approach to treatment.[7,8][Level of evidence: 3iiiDi]; [9,10,11][Level of evidence: 3iiiDiii]
Adjuvant Therapy
Treatment options for no residual disease, no disseminated disease
Radiation therapy
The traditional postsurgical treatment for these patients has been radiation therapy consisting of 54 Gy to 55.8 Gy to the tumor bed for children aged 3 years and older.[12] It is not necessary to treat the entire CNS (whole brain and spine) because these tumors usually recur initially at the local site.[13]; [14][Level of evidence: 3iiiA] When possible, patients should be treated in a center experienced with the delivery of highly conformal radiation therapy (including intensity-modulated radiation therapy or charged-particle radiation therapy) to pediatric patients with brain tumors.
Evidence (radiation therapy):
Focal radiation therapy has been used in certain cases.[16] In a small series of children with localized ependymoma, surgery alone was compared with adjuvant radiation therapy. Adjuvant radiation therapy appeared to improve PFS, even after adjusting for the extent of resection. In fact, a PFS benefit was observed for patients who received adjuvant radiation therapy after gross-total resection, compared with those who did not receive radiation therapy.[17] Additional research will be necessary to confirm these findings.
Proton-beam radiation therapy (a type of charged-particle radiation therapy) provides a possible advantage for targeting the tumor while avoiding critical normal brain and neuroendocrine tissues, whether the tumor is supratentorial or infratentorial. Seventy children treated with involved-field, proton-beam radiation at Massachusetts General Hospital between 2000 and 2011 (median age, 33 months; range, 3 months–20 years) had 3-year local control of 83%, PFS of 76%, and overall survival (OS) of 95%, with confirmation that subtotal resection was associated with an inferior outcome. Data demonstrating an advantage in terms of intelligence, adaptive skills, neuroendocrine deficiencies, and other morbidities do not yet show an advantage over other forms of conformal radiation therapy.[18]
There is no evidence to date that adjuvant chemotherapy, including the use of myeloablative chemotherapy,[19] improves the outcome for patients with totally resected, nondisseminated ependymoma. For this reason, current treatment approaches do not include chemotherapy as a standard component of primary therapy for children with newly diagnosed ependymomas that are completely resected.
A randomized trial evaluating the efficacy of postradiation chemotherapy in children who have had a gross-total resection is underway.
Treatment options for residual disease, no disseminated disease
Second-look surgery
Second-look surgery should be considered because patients who have complete resections have better disease control.[20] In some cases, further surgery can be undertaken after the initial attempted resection if the pediatric neurosurgeon believes that a gross-total resection could be obtained by an alternate surgical approach to the tumor. In other cases, further up-front surgery is not anticipated to result in a gross-total resection, therefore, adjuvant therapy is initiated with future consideration of second-look surgery.
The rationale for radiation therapy as described in the Treatment options for no residual disease, no disseminated disease subsection above also pertains to the treatment of children with residual, nondisseminated ependymoma. In patients with a subtotal resection, treatment with radiation therapy results in 3-year to 5-year PFS in 30% to 50% of patients,[15] although the outcome for patients with residual tumor within the spinal canal may be better.[21]
Preirradiation chemotherapy
One study demonstrated a benefit of preirradiation chemotherapy in children with near-total resection (>90% resection), with outcomes comparable to children achieving a gross-total resection followed by radiation therapy.[22] The Children's Oncology Group (COG) has completed a study of preirradiation chemotherapy in children with residual disease after up-front surgery to determine whether children treated with chemotherapy can achieve a complete response with chemotherapy or second-look surgery. Results are pending.
There is no evidence that high-dose chemotherapy with stem cell rescue is of any benefit.[23]; [24][Level of evidence: 2A]
Treatment options for CNS disseminated disease
Regardless of the degree of surgical resection, these patients generally receive radiation therapy to the whole brain and spine, along with boosts to local disease and bulk areas of disseminated disease. The traditional local postsurgical radiation doses in these patients have been 54 Gy to 55.8 Gy. Doses of approximately 36 Gy to the entire neuraxis (i.e., the whole brain and spine) are also administered but may be modulated depending on the age of the patient. Boosts between 41.4 Gy and 50.4 Gy to bulk areas of spinal disease are administered, with doses depending on the age of the patient and the location of the tumor. However, there are no contemporary studies published to support this approach.
The role of chemotherapy in the management of children with disseminated ependymoma is unproven.[25]
Treatment options for children younger than 3 years
Children younger than 3 years are particularly susceptible to the adverse effects of radiation on brain development.[26][Level of evidence: 3iiiC] Debilitating effects on growth and neurologic development have frequently been observed, especially in younger children.[27,28,29] Consequently, radiation therapy immediately after surgery in children younger than 3 years has historically been limited, with attempts to delay its administration through the use of chemotherapy.[30,31,32,33]; [34][Level of evidence: 2A]
Some, but not all, chemotherapy regimens induce objective responses in children younger than 3 years with newly diagnosed ependymoma.[30,31,32,33] Up to 40% of infants and young children with totally resected disease may achieve long-term survival with chemotherapy alone.[35][Level of evidence: 2Di]
Because of the known effects of radiation on growth and neurocognitive development, the use of radiation therapy in children younger than 3 years has been limited.
Conformal radiation approaches, such as 3-dimensional conformal radiation therapy, that minimize damage to normal brain tissue and charged-particle radiation therapy, such as proton-beam therapy, are under evaluation for infants and children with ependymoma.[15,36] When analyzing neurologic outcome after treatment of young children with ependymoma, it is important to consider that not all long-term deficits can be ascribed to radiation therapy because deficits may be present in young children before therapy begins.[15] For example, the presence of hydrocephalus at diagnosis is associated with lower intelligence quotient as measured after surgical resection and before administration of radiation therapy.[37]
The recently completed COG protocol (ACNS0121 [NCT00027846]) for children with ependymoma includes children aged 1 year and older. The trial is a prospective evaluation of postoperative radiation therapy. Results are forthcoming.
Treatment Options Under Clinical Evaluation for Newly Diagnosed Childhood Ependymoma or Anaplastic Ependymoma
The following is an example of a national and/or institutional clinical trial that is currently being conducted or is under analysis. Information about ongoing clinical trials is available from the NCI website.
No Residual Disease; No Disseminated Disease
Residual Disease; No Disseminated Disease
Current Clinical Trials
Check the list of NCI-supported cancer clinical trials that are now accepting patients with newly diagnosed childhood ependymoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI website.
Recurrence is not uncommon for all grades of ependymoma and may develop many years after initial treatment.[1] Late recurrence beyond 10 to 15 years has been reported.[2,3] Disease generally recurs at the primary tumor site,[4,5] although concomitant neuraxis dissemination may also be seen. Systemic relapse is extremely rare. At time of relapse, a complete evaluation for extent of recurrence is indicated for all patients.
The need for further surgical intervention is individualized based on the following:
In some cases, surgically accessible lesions may be treated alternatively by radiation therapy.
Radiation Therapy and/or Chemotherapy
Patients with recurrent ependymomas who have not previously received radiation therapy and/or chemotherapy should be considered for treatment with the following modalities:[6][Level of evidence: 3iiiB]
Regardless of treatment strategy, the prognosis for patients with recurrence is poor.[1] Entry into studies of novel therapeutic approaches should be considered.
Treatment Options Under Clinical Evaluation for Recurrent Childhood Ependymoma
Early-phase therapeutic trials may be available for selected patients. These trials may be available via Children's Oncology Group, the Pediatric Brain Tumor Consortium, or other entities. Information about ongoing clinical trials is available from the NCI website.
Check the list of NCI-supported cancer clinical trials that are now accepting patients with recurrent childhood ependymoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
General Information About Childhood Ependymoma
Added text to state that immunohistochemical testing has identified increased expression of markers of proliferation and increased expression of EZH2, a polycomb complex protein involved in epigenetic regulation of gene expression, as prognostic factors for greater risk of treatment failure (cited Li et al. as reference 30).
Treatment of Newly Diagnosed Childhood Ependymoma or Anaplastic Ependymoma
Added Ghia et al. as reference 11.
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
Purpose of This Summary
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of childhood ependymoma. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.
Reviewers and Updates
This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).
Board members review recently published articles each month to determine whether an article should:
Changes to the summaries are made through a consensus process in which Board members evaluate the strength of the evidence in the published articles and determine how the article should be included in the summary.
The lead reviewers for Childhood Ependymoma Treatment are:
Any comments or questions about the summary content should be submitted to Cancer.gov through the NCI website's Email Us. Do not contact the individual Board Members with questions or comments about the summaries. Board members will not respond to individual inquiries.
Levels of Evidence
Some of the reference citations in this summary are accompanied by a level-of-evidence designation. These designations are intended to help readers assess the strength of the evidence supporting the use of specific interventions or approaches. The PDQ Pediatric Treatment Editorial Board uses a formal evidence ranking system in developing its level-of-evidence designations.
Permission to Use This Summary
PDQ is a registered trademark. Although the content of PDQ documents can be used freely as text, it cannot be identified as an NCI PDQ cancer information summary unless it is presented in its entirety and is regularly updated. However, an author would be permitted to write a sentence such as "NCI's PDQ cancer information summary about breast cancer prevention states the risks succinctly: [include excerpt from the summary]."
The preferred citation for this PDQ summary is:
National Cancer Institute: PDQ® Childhood Ependymoma Treatment. Bethesda, MD: National Cancer Institute. Date last modified <MM/DD/YYYY>. Available at: http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq. Accessed <MM/DD/YYYY>.
Images in this summary are used with permission of the author(s), artist, and/or publisher for use within the PDQ summaries only. Permission to use images outside the context of PDQ information must be obtained from the owner(s) and cannot be granted by the National Cancer Institute. Information about using the illustrations in this summary, along with many other cancer-related images, is available in Visuals Online, a collection of over 2,000 scientific images.
Based on the strength of the available evidence, treatment options may be described as either "standard" or "under clinical evaluation." These classifications should not be used as a basis for insurance reimbursement determinations. More information on insurance coverage is available on Cancer.gov on the Managing Cancer Care page.
Contact Us
More information about contacting us or receiving help with the Cancer.gov website can be found on our Contact Us for Help page. Questions can also be submitted to Cancer.gov through the website's Email Us.
Call 1-800-4-CANCER
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.
Chat online
The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI websites and answer questions about cancer.
Write to us
For more information from the NCI, please write to this address:
Search the NCI websites
The NCI website provides online access to information on cancer, clinical trials, and other websites and organizations that offer support and resources for cancer patients and their families. For a quick search, use the search box in the upper right corner of each web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen web pages that are most closely related to the search term entered.
There are also many other places to get materials and information about cancer treatment and services. Hospitals in your area may have information about local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.
Find Publications
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).
Last Revised: 2015-09-24
This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
View More
Use our interactive symptom checker to evaluate your symptoms and determine appropriate action or treatment.
I want to...
1111 Duff Avenue Ames, Iowa 50010
515-239-2011 Email us
Ames 515-239-6877
Marshalltown 641-754-6877
Anywhere in Iowa 800-524-6877


text:
Well they say that you cannot change anything that has happened in the past. And there is no such way by which you can go back to time and mend things, which went wrong in the past. But what if you meet somebody, who can make you travel back into time and help you correct them? I'm sure you must have heard of something called a time machine.
An apple a day keeps the doctor away, but what if the doctor takes you away. Meet the doctor of the Doctor Who, who belongs to the Time Lord, a fictional extraterrestrial race. His 'larger than life' presence in the show's episodes simply captivates the viewers. Be ready to go back into time in Doctor Who episodes, as the doctor has invented a time machine called the TARDIS, a machine that makes time-travel a reality.
Doctor is known to take his companions back into time, with the help of the TARDIS, in order to mend all the wrong happenings in the past and this is how he helps people and becomes their pacifier.
Well, if you're eager to meet a doctor like him, then it's time for you to watch Doctor Who online. Go back into time because after that you won't repeat the phrase, 'let bygones be bygones.' Watch the most captivating presentation of the concept of time travel. Doctor Who series has been listed in the Guinness World Records for being the longest running science fiction series. Moreover, this science fiction series has been tagged as the most successful sci-fi show of all times. Hats off to its creators Sydney Newman, C. E. Webber and Donald Wilson, for delivering to us, such a great piece of work. You'd be happy to know that the show is in the midst of its 6th season and has already dished out more than 770 episodes. So, don't wait any further and meet the Doctor Who online on a reliable website.
Doctor Who is one show, which you must not miss, if you are a die hard admirer of the infinite elasticity of the human imagination that grants it the strength to take any direction and any form. Human mind often forays into an endless world of imagination and alters it with unthinkable modulation, which when compared with the real world, simply seems incomparable. So, let us celebrate the infiniteness of human imagination by laying our eyes on the Doctor Who series, which is nothing less than an epitome of creative-brilliance.
So what are you waiting for? A highly-charismatic and enterprising doctor is all ready to meet you.
|< Prev
|Next >

subset: commoncrawl


text:
I picked two of the more simple patterns, because I still don't fully understand how to read some of the harder ones... I'm workin' on it.
I also made her a necklace. I used a silver sterling chain and this tutorial for the loops. Basically, I single crocheted around plastic rings with embroidery floss, attached them and added the chain with a couple of jump rings.
I liked the necklace so much, I ended up making one for my mom and one for myself!


text:
AFC Wimbledon have confirmed that they have cut short George Porter's season-long loan from Burnley.
Porter made 24 league appearances for Wimbledon but the League Two club had the option to assess the situation in January and the winger has now returned to Turf Moor.
Wimbledon boss Neal Ardley said: "There was a review period in January and George's form had dipped a bit before Christmas.
"George was therefore left out of the squad when we decided to change our shape slightly.
"George was unhappy about not getting game time and Burnley were looking to see if things were happening the way they wanted them to.
"Both clubs therefore decided it would be best for George to go back to Burnley so that they can review his situation."


text:
Who Hogs the Bed in Sioux Falls?
The picture above was recently posted on Instagram, implying that most women hog the bed. However, that might not be the case here in Sioux Falls.
We posted the picture on Facebook to get people's feedback. Though many people agreed with the picture…
- Crash OnThe Bee – SO true, and I'm a foot taller and one hell of a lot heavier than my wife, yet left with the edge. WTH?
- Christina Palmer – Absolutely ..
- Bee Urfer – My bf would agree
- Kelly Walsh Cacaro – That seems about right!
- Kelsey Miiller – My boyfriend would agree
- LaShawnda Enright – yes, but only problem is that his side wouldn't have any covers.
It seemed more people disagreed with the picture. Of course, most of them were women, so how objective could they really be (hey, we kid because we love)…
- Lanete Kotilnek – When I was married, it was the exact opposite. I basically had to cling to the edge of the bed while he and the 2 dogs pushed me out…
- Tina Vostad Pruett – The opposite was true with my ex-husband! The "His" side is about how much space I had to sleep on each night.Angela 'Hecht' Blommer – Completely opposite for me and my husband.
- Beth Boden – Sadly, this doesn't reign true for me! My significant other has a tendency to push me up against the wall/sleep diagonally! So really he takes up more room than I do!
- John Buckmillerjohn – other way around
- Jessica Braun – Complete opposite for us!
- Heather Axsom – no!! my bf is super tall and skinny and he owns the her side of the bed lol
- Wendy Fitzgerald – Hell no
- Jenny West – that's the oppiset at my house
- Charity Dupuy – My husband takes up more of our bed then I do
- Sharona Neuroth – I wish, but total opposite for me. My honey is a bed hog.
Of course, there were many who pointed to a completely different source of bed-hoggery (is that even a word)?
- Clay Renshaw Sr. – Where does the dog sleep?
- Katie Visser – Not if you have dogs, they will be in the her side spot, we will be in his spot.
- Caleb Ryan – Ya wheres the space for the cute husky and pomeranian husky?!
- Jessica Sachtjen – Nope… we both sleep in the his part and our dogs take up the hers part!
- Kate Garrison My boyfriends thinks they need to add a section of "his side" for the dog too
- Mary Muchow Brandsma – NO!!! Totally opposite, and add a dog space in the middle!!!
- Teia Rolfes – 60% hubby, 20% cats, 20% me. Mike Rolfes
And in one case, I think we may have made the bedroom a very uncomfortable place…
- Kyle Timmerman – I agree with the pic Pam Timmerman!!!
- Pam Timmerman – I agree other way around!
So, what do you think? Who takes up most of the room in the bed?


text:
Category: 2012 boys' names
Baby names 2012 promise revolutionary new directions in the continuing and escalating search for meaning coupled with originality. That can be a hard bill to fill when it comes to baby names, pushing parents in 2012 to look to some fresh sources and create names that have never been heard before.
Every year, it seems, people become more aware of the power of names. And yet names are still free and universal, which increases the pressure to find that one perfect name that defines and encapsulates all your hopes and dreams for your child.
Here, the 12 hottest trends for Baby Names 2012.
Post Categories:


text:
Thu, Jun 20, 2013 at 11:16 PM
Nelly – Get Like Me ft. Nicki Minaj &...
Recently Nelly teamed up with Nicki Minaj & Pharrell Williams for 'Get Like Me', the new track from his upcoming album M.O.
Yesterday the rapper made the announcement for when the song will hit the iTunes store.
"@Nelly_Mo: #GETLIKEME hits iTunes 7/2 .....!!!! @NICKIMINAJ @Pharrell," he tweeted.
Also, according to Nicki's tweets, visuals for the song are scheduled to be shot next week.
XD :D COOOOOOOL!!!!!!!!! I LIKE DA Song!!!!!!!! ITS PRETTY DOPE!!!!!!! good JOD NELLY! BUT NCKI'S VERSE WAS DA highlight OF DA WhOOOOOOOOLE Song!!!!!!!!!! her VERSE WAS SSSSSSSSOOOOOOOOO hot, DOPE, FLY, AND She SLAAAAAAAAAAAYED!!!!!!!!! her VERSE IS STILL DEFINATELY ON REPLAY OVER AND OVER AAIN!!!!!!!!!! I have LEARNED MOST OF her VERSE ALREADY!!!!!!!!! IT WAS JUST FIRE!!!!!!!!!!! BEYOND AMAZIN!!!!!!!!!!!!! I LOOOOOOOOVE her WORDPLAY!!!!!!!!!!!!!!! NICKI IS DA Metaphor QUEEN!!!!!!!!!!! She IS DA QUEEN IN Everything She DOES!!!!!!!! BUT LIKE I SAID, I have had AN IPOD FOR Three YEARS With NO ITUNES ON IT. :( BUT DONT WORRY TEANNA When I get OLDER AND FAMOUS I WILL have AN ITUNES CARD DAT WILL have $500 ON IT!!!!!!!!! I REALLY REALLY NEED IT. ESPECIALLY NOW SINCE NICKI has ALL DESE FEATURES OUT!!!!!!! IT IS A LOT OF STUFF going ON With NICKI DIS YEAR!!!!!!!!!!! I KINDA CANT KEEP UP. I AM SOOOOOOOOO PROUD OF her WORDS CAN'T EXPRESS!!!!!!! KEEP WINNIN NICKI AND ALWAYS BELIEVE IN god AND DONT give UP!!!!!!!!!!!!!!!! TEAM MINAJ TILL DA Death OF ME!!!!!!!!!!!!!!!!!!! YMCMB, TEAM MINAJ, AND NICKI MINAJ #1 STUNNAS BABY!!!!!!! CYYYYYYYYYYEEEEEEEEAAAAAAAAAAA!!!!!!!!! LOVE YOU NNNNNNNNNNIIIIIIIIIICCCCCCCCKKKKKKKKKIIIIIIII!!!!!!!! MMMMMMMMMMMMUUUUUUUUUUUUUUUUAAAAAAAAAAA!!!!!!!!!!!


text:
No Hidden Fees - No Credit Card Surcharges - Low Shipping Rates
Images shown may not be an exact representation of the actual product.You may contact us if you have questions about the exact specifications of this item.
The Mosin–Nagant (Russian: ???????? ??????, ISO 9: Vintovka Mosina) is a bolt-action, internal magazine-fed, military rifle invented under the government commission by Russian and Belgian inventors, and used by the armed forces of the Russian Empire, the Soviet Union and various other nations.
More from Wiki:
Mosin–Nagants have been exported from Finland since the 1960s as its military modernized and decommissioned the rifles. Most of these have ended up as inexpensive surplus for Western nations.
In Russia the Mosin–Nagant action has been used to produce a limited number of commercial rifles, the most famous are the Vostok brand target rifles exported in Europe in the 1960s and 1970s chambered in the standard 7.62x54mmR round and in 6.5x54mmR, a necked down version of the original cartridge designed for long range target shooting.
A number of the Model 1891s produced by New England Westinghouse and Remington were sold to private citizens in the United States by the U.S. government through the Director of Civilian Marksmanship program between the two World Wars. Rifles from this program are valuable collectibles. Many of these American-made Mosin–Nagants were rechambered by wholesalers to the ubiquitous American .30-06 Springfield cartridge; some were done crudely, and others were professionally converted. Regardless of the conversion, a qualified gunsmith should examine the rifle before firing, and owners should use caution before firing commercial ammunition.
With the fall of the Iron Curtain, a large quantity of Mosin–Nagants have found their way onto markets outside of Russia as collectibles and hunting rifles. Due to the large surplus created by the Soviet small arms industry during World War II and the tendency of the former Soviet Union to retain and store large quantities of old but well-preserved surplus (long after other nations militaries divested themselves of similar vintage materials), these rifles (mostly M1891/30 rifles and M1944 carbines) are inexpensive compared to similar surplus arms, and possibly the cheapest firearm of the day, often found at under $100 USD.
There is serious collector interest in the Mosin–Nagant family of rifles, and they are popular with target shooters and hunters, though a downfall of these rifles in their new hunting and target shooting roles is the lack of elevation-adjustable sights. The notched rear tangent iron sight is adjustable, and is calibrated in hundreds of meters. The front sight is a post adjustable for elevation in the field. Windage adjustment is done by the armory before issue. The battle setting places the round within +/-33 cm from the point of aim out to 350 m (380 yd). This "point-blank range" setting allows the shooter to fire the gun at any close target without adjusting the sights. The field adjustment procedure for AK-47, AKM and AK-74 family requires 4 rounds to be placed in a 15 cm group at a distance of 100 meters. Longer settings are intended for area suppression. These settings mirror the Mosin–Nagant and SKS-45 rifles which the AK-47 replaced. This eased transition and simplified training.
The "point-blank range" setting of the Mosin–Nagant is due to the necessity of quick instruction of conscripted soldiers. However, the lack of fine adjustment leaves some hunters with the desire to add a scope and, as of this writing, two companies make adjustable sights for the Russian version of this rifle, Mojo and Smith-Sights. Generally viewed as highly accurate, these rifles show a capability of two-inch groups or better at 100 yards/meters when used with good ammunition and are capable of taking most game on the North American Continent when correct ammunition is used.[22] If the barrel is free-floated or bedded and has a sound bore, and if the trigger is worked on to lighten it and improve let-off, accuracy of minute of angle is possible with scoped Model 91/30s.
In the years after World War II, the Soviet Union ceased production of all Mosin–Nagants and withdrew them from service in favor of the SKS series carbines and eventually the AKseries rifles. Despite its growing obsolescence, the Mosin–Nagant saw continued service throughout the Eastern bloc and the rest of the world for many decades to come. Mosin–Nagant rifles and carbines saw service on many fronts of the Cold War, from Korea and Vietnam to Afghanistan and along the Iron Curtain in Europe. They were kept not only as reserve stockpiles, but front-line infantry weapons as well.
Virtually every country that received military aid from the Soviet Union, China, and Eastern Europe during the Cold War used Mosin–Nagants at various times. Middle Eastern countries within the sphere of Soviet influence — Egypt, Syria, Iraq, Afghanistan and Palestinian fighters — have received them in addition to other more modern arms. Mosin–Nagants have also seen action in the hands of the Mujahadeen in Afghanistan during the Soviet Union's occupation of the country during the 1970s and the 1980s. Their use in Afghanistan continued on well into the 1990s and the early 21st century by Northern Alliance forces.
Even after the collapse of the Soviet Union, Mosin–Nagants are still commonly found on modern battlefields around the world. They are being used by insurgent forces in the Iraq Warand the current war in Afghanistan. Separatists have also used the rifles alongside more modern Russian firearms in the Second war in Chechnya.[9]
Impact Guns is the gun shop for all your shooting needs. We offer a wide selection of firearms, including: handguns, shotguns, rifles, ammunition, rifle scopes and optics, as well as collectible machine guns and other NFA/Class 3 guns. Impact also services the needs of law enforcement and military with our wide variety of tactical weapons and accessories. Shop online through our 256-bit Secure Sockets Layer encrypted online gun store 24 hours a day!


text:
PICUM » News » PICUM News » PICUM REPORT LAUNCH: Strategies to End Double…
PICUM REPORT LAUNCH: Strategies to End Double Violence Against Undocumented Women - Protecting Rights and Ensuring Justice"
Launched at the European Parliament
"Strategies to End Double Violence Against Undocumented Women -
Protecting Rights and Ensuring Justice"
BRUSSELS, 21 June 2012
The Chair of the 'Committee of the European Parliament on Women's Rights and Gender Equality', MEP Mr. Mikael Gustafsson (GUE/NGL) was joined by MEPs Ms. Sirpa Pietikäinen (EPP) and Ms. Jean Lambert (Greens/ EFA) in launching PICUM's seminal report and addressing the need to improve access to justice for undocumented women in Europe.
Across the EU, undocumented women are turned away from women's shelters and risk arrest or deportation if they contact the police. As one social worker in Belgium explained, "Undocumented women often stay in their situation of violence until they're beaten to death because they don't dare to go to the police or ask for help."
To address this urgent situation, PICUM's report provides an overview of the laws, practices and partnerships that respect rights and ensure justice for all women in Europe without discrimination. It shows what works, where, and how it came about.
Responding to the growing recognition to place women's protection needs ahead of their migration status, PICUM shows how this can be done practically, coherently and in accordance with the duties of law enforcement, legislators, civil society, and policymakers.
The examples in this report are a testimony to the agency, capacity and impact of migrant women themselves in bringing about change. As one undocumented woman told PICUM, "We will continue to fight for our rights, for rights of all migrants; especially for those working hard in this country."
Read it, Learn from it, and Share it.
Download it now in EN FR ES
PICUM is available for interviews or to provide further information on this report.
CONTACT: e-mail: email@example.com / tel: +32 (0)2 210 17 80


text:
Posted 6 years ago
(1 item)
Does anyone have any idea what this is? My gf parents have it and don't have any clue what it is. I'm assuming its something from one of the 60's world series teams but not sure! If someone has any idea please inform me. Thanks!


text:
Kuroda stifles Blue Jays with eight two-hit innings
Adams, Romine help NY beat Toronto for seventh time in eight games
NEW YORK -- The Yankees of 2013 were expected to be an old story, not one rehashed and retold, but one with wrinkles, one that prompted observers to count the rings in the trunk and gray hairs on their heads. Aged to perfection was 2009. This season was merely about age, too much of it. The Yankees were the appropriate age to fall and not get up and to finish among the also-rans in the American League. And when injury visited them and then became guilty of felony piling on, the adjusted assessments were for an even more bleak season.
At the same time, the Blue Jays of 2013 were expected to move north in the standings, one year after the fall of the Red Sox and simultaneous with the decline of the octogenarians in the Bronx.
Now, 42 games into their seasons, the Yankees are in first place in the AL East, the Jays are in last, nine games back. And the status of each is due, in large part, to the Yankees' dominance of the team from Canada.
The Yankees had their way with the Jays again Friday night. Their 5-0 victory was their seventh win in eight games against John Gibbons' disappointing team. This one was a byproduct of wonderful pitching by 38-year-old Hiroki Kuroda and the exploits of a couple of kids who have yet to earn their (pin)stripes.
Kuroda contributed eight innings of two-hit pitching, and 20-somethings David Adams and Austin Romine, each an understudy for an understudy, made significant contributions to an offense that overcame Mark Buehrle. Derek Jeter, Mark Teixeira, Kevin Youkilis and Francisco Cervelli are baseball-incapacitated. But the kids are all right.
Adams, in his third game in the big leagues, produced two hits and scored twice; Romine, now a veteran of eight games, had two hits, one RBI and one run scored. Kuroda and the kids had some help, but they were primarily responsible for the Yankees' eighth victory in 11 games -- also the Jays' first loss in five.
Make no mistake, these are kids, if not by calendar, then by resumé or appearance. In the afterglow of this one, a Yankees minion slipped a parking pass on the stool in front of Adams' locker. "Proof you've made it," the rookie third baseman was told. "I don't even have a car here," he said. Some wondered whether he were old enough to have a license.
Vernon Wells, the veteran who measures time by Yankees injuries -- "Three injuries ago, we yada, yada, yada" -- noted that the young players seem quite comfortable in their new surroundings then reasoned, "They should because they were all together down there."
Adams turned 26 this week. Romine is 24. The two had combined for 19 at-bats, all Romine's in 2011, before April 27. And there was Romine catching a pitcher 14 years his senior.
Kuroda surrendered a leadoff double by Melky Cabrera on the third pitch of the game. Cabrera remained on second base. Two innings later, Kuroda issued a walk and picked off the man he had passed. And in the seventh, Edwin Encarnacion singled on a 3-2 pitch. That was it until the ninth for a team that had scored 33 runs in the three games that preceded its second visit to the Stadium this year.
Kuroda's replacement was 25-year-old Preston Claiborne. He allowed two hits, but he was all right, too.
Romine and Joe Girardi indicated Kuroda had an uncommon degree of precision on his three pitches -- fastball, slider, splitter. He threw 109 pitches and struck out five. Girardi was not inclined to have his starter pitch the ninth.
"He's not 25 either," the manager said, referring to 40-year-old [and now sidelined] Andy Pettitte. "But he acts like it."
So Girardi protects Kuroda from himself. It's not about one start, it's about 35.
"He's definitely one of the better ones in the American League," Gibbons said. "He's had our number. That's the third time this year we haven't been able to do anything with him."
Kuroda, who has won four of his five most recent starts, has won two starts against the Jays, and he was the starting pitcher in another Yankees victory against them.
The Yankees scored in the first, fifth and seventh innings against Buehrle with a modicum of traditional Bronx firepower. Brett Gardner tripled to left-center field on Buehrle's first pitch. His third triple was more a matter of speed and the inability of the Jays' outfield to cut off the hit before it rolled to the warning track. After a walk to Jayson Nix, Gardner scored on a ground ball to second by Robinson Cano. The RBI was the 27th for Cano, which leads the team.
For one night, at least, the Yankees had abandoned their standard operating procedure; they scored in the first inning. Even with the one run against Buehrle, they have been outscored, 32-13, in the first. The 32 is a lot, the 13 is few. And the ratio is quite odd for a team with a winning record (26-16). But it is an unusual season from the team in first place.
Buehrle seemed uncomfortable in the first inning. Renowned for working quickly, his on-mound behavior was conspicuously deliberate. His pace quickened dramatically thereafter.
The Yankees had no other baserunner until Adams led off the fifth with a single. After a one-out single by Romine and a walk to Gardner, a sacrifice fly by Nix produced the run. Kuroda had been so effective to that point, the two-run lead appeared to be an ample margin for error.
The margin for victory became much larger when the Yankees produced hits in four straight at-bats in the seventh. A double by Adams, a bunt single by Ichiro Suzuki and a ripped double to left by Romine scored Adams and forced Buehrle from the game. Aaron Loup allowed a single through the left side by Gardner that scored Ichiro, and Nix's second sacrifice fly produced the third run.
That was that. Not all stories about the Yankees of 2013 are old, after all.
Marty Noble is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.


text:
Hero Nutritionals was the first company to deliver gummy vitamins, making it easy and tasty for kids and adults alike to take nutritional supplements. The Yummi Bear line of children's products includes multivitamin and mineral supplements, Fish Free Omega 3-6-9, Vitamin D3 and more. After the success of Yummi Bears supplements for kids, Hero Nutritionals launched Slice of Life, a full line of all natural, fruit flavored gummy vitamins and supplements for adults that includes Energy +B12, Vitamin C + Pomegranate and several other formulas.
You're now signed up to receive exclusive deals and savings opportunities!
Thank you for your interest and be assured that you will continue to receive our emails at this address.
We are having trouble processing your request. Our apologies! Please try again later.


text:
Founded back in 1936, Butlins is a brilliant British staple; a bit like fish and chips, roast dinners and the Queen. Quite simply, it offers the quintessential UK family holiday. However, a lot has changed since its creation in the flirty 30's and nowadays Butlins, with its range of top-notch accommodation, draws in holidaymakers of all backgrounds and budgets. So, if you are looking for a frolicsome break with an extra strong dosage of fun, then today's kgbdeal is sure to suffice…
For just £349, you and a loved one can treat yourself to a jam-packed escape to the one and only Butlins in Minehead. Enjoying a seven-night stay and breakfast and dinner each day, you can spend your time hitting the restaurants, luxuriating by the pool and visiting the nearby beach. This bonanza break would usually set you back up to £810, but with a saving of up to 57%, you can afford to treat yourself!
about Butlins Minehead
Whether you're looking for a relaxing time or a fun-filled short break (or a mix of both), Butlins is a great option for your summer holiday. There's plenty to keep you excited, and it's entirely up to you how much or how little you do. Butlins Minehead offers the perfect blend of nature and adventure. Get out and about to explore the stunning Exmoor National Park, have a go at coast-steering or take a Land Rover safari. Why not relax with a historic wander around Dunster Castle, swing by the local golf course or just stroll along the sandy beach? Bliss! Whatever you're into, Butlins have got it covered!


text:
'ignorance,' nescience, unknowing; synonymous with delusion (moha, s. mūla), is the primary root of all evil and suffering in the world, veiling man's mental eyes and preventing him from seeing the true nature of things. It is the delusion tricking beings by making life appear to them as permanent, happy, substantial and beautiful and preventing them from seeing that everything in reality is impermanent, liable to suffering, void of 'I' and 'mine', and basically impure (s. vipallāsa). Ignorance is defined as 'not knowing the four truths, namely, suffering, its origin, its cessation, and the way to its cessation' (S. XII, 4).
As ignorance is the foundation of all life-affirming actions, of all evil and suffering, therefore it stands first in the formula of Dependent Origination (paticca-samuppāda). But for that reason, says Vis.M. (XVII, 36f) ignorance should not be regarded as "the causeless root-cause of the world ... It is not causeless. For a cause of it is stated thus 'With the arising of cankers (āsava) there is the arising of ignorance' (M. 9). But there is a figurative way in which it can be treated as a root-cause; namely, when it is made to serve as a starting point in an exposition of the Round of Existence ... As it is said: 'No first beginning of ignorance can be perceived, Bhikkhus, before which ignorance was not, and after which it came to be. But it can be perceived that ignorance has its specific condition (idappaccaya)" (A.X.61). The same statement is made (A.X.62) about the craving for existence (bhava-tanhā; s. tanhā). The latter and ignorance are called "the outstanding causes of kamma that lead to unhappy and happy destinies" (Vis.M. XVII, 38).
As ignorance still exists - though in a very refined way until the attainment of Arahatship or Holiness, it is counted as the last of the 10 fetters (samyojana) which bind beings to the cycle of rebirths. As the first two roots of evil, greed and hate (s. mūla), are on their part rooted in ignorance, consequently all unwholesome states of mind are inseparably bound up with it. Ignorance (or delusion) is the most obstinate of the three roots of evil.
Ignorance is one of the cankers (āsava) and proclivities (anusaya). It is often called a hindrance (nīvarana; e.g. in S.XV.3; A.X.61) but does not appear together with the usual list of five hindrances.
'delusion', is one of the 3 unwholesome roots (mūla). The best known synonym is avijjā.
retrofuturist wrote:Are they completely identical in meaning?
nathan wrote:Does ignorance predominate in our individual lives and thoughts and/or in the state of affairs in the world, or not?
nathan wrote:What kind of a role does ignorance play in the lives of individuals and in the world overall and how does it express itself?
nathan wrote:What kinds of personal insights have you had into the nature of ignorance?
PeterB wrote:It seems to me that the word "ignorance" is being used in more than one way here. Avijja is more than an absence of knowledge concerning the factual, measurable world.
That's an interesting distinction. If we distinguish the one from the other along those lines it might then be useful to describe or define the learned ignorance (or 'self imposed' ignorance) as, say, 'delusion' as opposed to the general background ignorance of the generally and/or specifically unknown.PeterB wrote:Its not only that we are ignorant about things...although we may be and that might be significant in terms of our lives...its that the first link in the chain of dependant origination is Avijja. Its the bedrock of our false sense of self.
We could in fact be very learned in a particular sense, but our condition is still one of Avijja. Conversly we could be unlearned in a conventional sense and still break the chain of causation.
Avijja is a question of identity or identification. Its something we do...it is active.
It is not an absence of factual data or an inability to interpret such data.
Does ignorance predominate in our individual lives and thoughts and/or in the state of affairs in the world, or not?
Maybe, maybe not. There is a spectrum of thought on the subject in this thread already. Everything from ignorance narrowly defined as specifically ignorance of annata to ignorance quite broadly defined as the primary root of all evil and suffering in the world. I prefer the much wider definition and I think the examination and consideration of ignorance can be very beneficial in the widest possible context but I can also see why the Buddha would teach an approach to overtaking ignorance in the one place where it is perhaps most vulnerable, in the context of 'self'-delusion. One aspect of this that I find interesting is how broadly resilient ignorance is beyond the one context where it can most readily be undermined by the application of the eightfold path.appicchato wrote:Does ignorance predominate in our individual lives and thoughts and/or in the state of affairs in the world, or not?
Does, or is?...either way all one has to do is look around to answer that one...
Maybe, maybe not.
appicchato wrote:Maybe, maybe not.
One size fits all?...this applies to everything in life...
Return to "Connections to Other Paths"
Users browsing this forum: No registered users and 64 guests


text:
New York and California had led the way to a radical liberalization of abortion laws, resulting in the deaths of millions of innocent babies. Once some states legalized abortion, the floodgates were open to all and it was only a matter of travel costs for those seeking abortions.
Fundamental rights can have some state-by-state differences (like free speech), but fundamental rights are not state issues. We fought a civil war over that very issue.
It made sense to have our first YAF meeting focus on the rapid growth of illegal abortions. Therese Willke and Chuck Donovan from Cincinnati, Ohio, both attended because they had been involved in the close fight to keep abortion illegal in Ohio. Therese's parents, who were a doctor and a nurse, were early leaders in right to life. Therese's mom also created a little silver pin of two tiny baby's feet that is still used today.
Dr. Rice was already, pre-Roe v. Wade, the most feared pro-life speaker in the nation by the abortion advocates.
Our meeting had a small but respectable turnout in the late fall of 1972. Then on Jan. 22, 1973, the ground shifted.
In an incredibly poorly written political decision (not a legal one, there was no "right to privacy" on which the decision hinged), the Supreme Court banned prohibitions on abortion. Within hours, Dr. Rice met with Maryland Rep. Larry Hogan and sketched out the first Human Life Amendment, which was introduced almost immediately.
Back at Notre Dame, we formed a group called the Student Coalition for the Human Life Amendment with Therese Willke and I as co-chairmen, and Chuck as executive director. Dr. Rice was our faculty advisor.
Thirty-nine years ago on the first anniversary of the tragic Supreme Court decision defenders of the right of innocent babies to live rather than be killed began marching as a sign of commitment to continuing efforts to overturn the decision.
Obviously none of us thought it would take this long. After the first few years, organizations were created to help young mothers cope with unexpected pregnancies as well as low-income moms or those without family support for their baby.
This Saturday at noon there will be yet another March for Life in downtown Fort Wayne. Until the slaughter stops, the marchers in the streets across America will be a silent testimony to the shame of our blood-stained nation.
Our hearts are broken over the tragic deaths of the schoolchildren in Connecticut, but they should also be for the tiny ones killed before they could even get to preschool.
Stand up and be counted at noon this Saturday. We'll take a social issues moratorium when the killing ends.


text:
We have about 500 web pages that we need to extract data from. Each page contains the following metadata, but with a different date.
<meta name="dcterms.issued" content="2005-12-23" />
We want to extract the date from each file so that we know when the page was issued.
Any help is appreciated.
That was more tedious than I thought:
Where do I send my bill
Nice one John
Thank you I am pleased you like it.
The OP posed the question and never returned
I hope others find the code useful.
It was to me. I am a new forum user, I joined for this answer.Please can you help me? I read that Dublin Core released its spec in the (achieved) attempt to conform with RDFa Lite. Does anyone know whether automated systems already exist with the purpose of extracting Schema: metadata with the native attributes???? Otherwise it is better to drop the <meta@name> and move to @property.


text:
Last night we were guests at a special premiere showing of Disney*Pixar's MONSTERS UNIVERSITY. My husband, 8 year old and I all were so excited to see the movie and it did not disappoint. The main characters, Mike Wazowski and James P. Sullivan are back and full of all their usual fun. MONSTERS UNIVERSITY is the prequel to Monsters Inc. and tells the story of how Mike and Sully met while studying "scaring" at MU. They were not best friends from the start but the films follows them all the way through to their partnership at Monsters Inc.
MONSTERS UNIVERSITY focuses on Mike Wazowski, who has dreamed of being the best "scarer" since he took at a field trip as a child to Monsters Inc. The problem is that Mike (voice of Billy Crystal) is not very scary. He studies hard and knows all the scaring tricks but he can't scare anyone. Sulley, voice of John Goodman, is a natural born scarer but does not think he needs to study. MONSTERS UNIVERSITY follows their trials, tribulation and antics. The movie will keep child and adults entertained for the entire 103 minutes (which includes the Pixar short BLUE UMBRELLA). BLUE UMBRELLA is a great short and made me want to watch it again.


text:
Flexibility Driving the Future of Automation
Flexible Production, Cloud Computing Pave the Way to Future for Rockwell Automation and Users
To help their users and customers survive in the present and thrive in the future, a trio of Rockwell Automation's technical experts and partners delivered a series of presentations this week at the Manufacturing Perspectives press event leading up to Automation Fair 2012 in Philadelphia.
One of the cornerstones enabling the flexibility of manufacturing so crucial to the operations of many of Rockwell Automation's manufacturing customers is the company's long and fruitful partnership with Cisco Systems. Maciej Kranz, vice president and general manager of the Connected Industries Group at Cisco, and Sujeet Chand, senior vice president and CTO at Rockwell Automation, jointly reported how they're striving to make flexible production and cloud-computing services more mobile and secure.
"Research shows about 63% of companies are allowing staffers to bring smart phones and other mobile devices onto their plant floors to allow access to information and aid in collaboration, but at the same time about $60 billion is being spent on cybersecurity," said Kranz. "So as connected apps drive enterprise convergence, there's more need for security too."
Chand explained, "The sheer volume of production data is so great that many users are drowning in it, and this isn't helped by all the proprietary formats they have to deal with. What they need is to bring actionable information out of all that data. Fortunately, enhanced connectivity is continuing to evolve, and the key enabler is open, standard Ethernet. In fact, together we've been using our joint Reference Architecture to develop and produce the switches and access points to bring more Ethernet to the plant floor, and then securely connect it to the enterprise level, back-end business networks and supply chains."
Chand added that Rockwell Automation and Cisco's efforts on improving Ethernet networking have inevitably brought it to cloud computing. "The cloud is allowing users to move legacy information and data processing from hardware to virtual systems, which allows greater mobility, improves analytics and optimization, and enables the factory of the future. However, these must be assisted by perimeter security, VPNs and firewalls, threat identification and cloud-based security infrastructures, which can give users the converged, secure networks they need for successful and safe collaboration."
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Want to participate in the discussion?Register for free
Log in for complete access.
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments


text:
Santos Tickets
Find the Santos tickets you're looking for on viagogo, the world's largest ticket marketplace. Select a match from the Santos fixtures to view the range of tickets available. You can also sell your spare Santos tickets on viagogo, and listing tickets is free. All Santos tickets are covered by the viagogo Ticket guarantee!
Sign Up for Santos Ticket Alerts
Sign up for the latest information on upcoming Santos events. Be the first to know when Santos tickets go on sale!
The email address you entered is invalid


text: I know this probably doesn't apply to a lot of you, but does anyone know about the upcoming Janesville Jammer tournament in Janesville, WI? I've been trying to look up info, but can't find it on the web. The only stuff I can find is about last year and I know it's coming up in the beginning of May. If anyone has any information please let me know.


text:
Cards have foil on the front but not the back. Foil aspects cannot be customized, but most other elements can be changed with free designer assistance.
Need expert help? Our Wedding Design Specialist is here for you.
We are excited to help make your wedding invitations and matching items perfect. We can help with custom colors, layout changes, photo editing, and even etiquette advice. We will even send you a digital proof of the changes before you actually purchase.
You can request edits by clicking "Request free designer assistance" at the end of personalization. If you have questions, please contact us at any time online or via phone toll-free at 877-77-CULTURE (877-772-8588).
The boldness of the foil blocks create a stunning wedding suite that is both sophisticated and modern. Select a matching RSVP card to make it easy for your invitees to respond to your wedding invitation. We'll address your RSVP cards and we'll print each card and envelope on 100% recycled paper.
See how Paper Culture compares to Tiny Prints, Minted, Shutterfly, & Snapfish
- Card Type:
- Flat Card
- Card Size:
- Cards 4.9" x 3.5" - Flat
- Paper:
- 130lb, 100% post consumer recycled paper
- Envelopes:
- White envelopes made from 100% post consumer recycled paper.
- Delivery Options:
Shipped To You
$8.99 flat-rate (via Ground)
- Price Per Card:
- 10-20
- $2.89
- 21-50
- $2.59
- 51-90
- $2.39
- 91-199
- $2.19
- 200-299
- $2.09
- 300+
- $1.99
As a designer I am most inspired by beautiful patterns, interesting textures, cheerful color palettes, and thoughtful typography. I love creating new and beautiful pieces that evoke a sense of elegance and sophistication through simplicity. I hope you enjoy my work as much as I enjoyed creating it! :)


text:
Browse the web version of the brochure
starting with the Table of Contents.
You can also view the plants at the Lady Bird Johnson Wildflower Center's Native Plants Database which has additional photos & information for individual plants.
This publication is also available
as a PDF document. You will need Adobe Acrobat to view or print it. The file
is 5.3 MB and is available here.
Warning: This file is large and can take a long time to download over a 56.5 Kbps modem connection.
Back to the Plant Conservation Alliance Website
by USFWS
BayScapes Conservation Landscaping Program
Last updated: 23 March 2005


text:
Sandals Rock Springs WY
Rock Springs, WY
Rock Springs, WY
Rock Springs, WY
Bitter Creek, WY
Laramie, WY
Rock Springs, WY
Rock Springs, WY
Rock Springs, WY
Casper, WY
Cody, WY
the greatest invention of the 21st century
as you can see, we have a new feature here at painfully hip. its called visual search technology. i know! i kiss you!
if you see a little star icon on a photo on the site, give it a little tease with your mouse cursor. you can click on the piece that is outlined, et voila! hundreds of similar-looking products. and it gets better. you can use the slider in the upper right to designate exactly how much you want to pay for said product. there are also sliders for color and style importance too. superfancy!
i did a visual search on these gorgeous gold ankle strap sandals , turned down the color preference and the price range, and look at the stunners that came up:
um. love them. want them. have to have them. the perfect simple sandal with gladiator flair. and so effing cheap at only $21.99 !...
Click here to read the rest of this article from Painfully Hip


text:
Camera shy Forest Green fail their screen test
11:43am Friday 28th March 2014
11:43am Friday 28th March 2014
CAMERA shy Forest Green slipped to defeat at lowly Southport in a game played in atrocious conditions at the Merseyrail Community Stadium, writes Richard Joyce.
Rovers kept up their poor record in front of the BT Sport cameras as they failed to take up the opportunity of sneaking into a place in the Conference Premier play-off zone.
A flood of rain lashed down throughout the evening with heavy thunder and lighting overhead too but Ady Pennock's side couldn't make it three consecutive wins on the bounce at Haig Avenue as the second half conditions deteriorated badly - with many calling for an abandonment.
Rovers had dominated early on however Southport forced their way into the game and took an early second half lead thanks to a thunderbolt header from Karl Ledsham.
They wrapped up their win with a superb strike just past the hour mark when Republic of Ireland under 21 international fizzed a low shot into the back of Sam Russell's net.
Luke Rodgers was handed his first start in a Rovers jersey up front alongside Lee Hughes. Al Bangura meanwhile returned in midfield with Aarran Racine taking the place of the injured Dale Bennett in the back line on his return from suspension.
And it was the returning Racine who forced Forest Green's first chance on goal after nine minutes. Anthony Barry's cross found the centre back who could only head over the bar.
Rodgers then tried his best to find his first Rovers goal after Danny Hurst had spilt a cross into the strikers path but he couldn't get past the Southport defence.
Strike partner Hughes then directed an effort on goal himself but the former West Brom man's clever lifted attempt on the turn could only find the roof of the net.
Forest Green had bossed the early exchanges but the home side began to find their feet midway through the half as Vinny Mukendi speared a shot from 25 yards wide.
Russell was then called upon to make a fine stop to deny what looked set to be the games opening goal.
Chris Stokes weak back pass was picked up by Blackburn Rovers loanee O'Sullivan who marched towards goal only to be foiled by an excellent save from Russell.
The Rovers keeper was at it again from a Southport corner which followed moments later as he smothered a low Aristote Nsiala attempt.
The rain continued to lash down during half time as conditions worsened severely in the second half.
Nevertheless, it was the hosts who found the matches opening goal four minutes after the interval, as Ledsham met O'Sullivan's pin-point cross with fine aplomb to head in his side's opener.
David Fitzpatrick's long range strike for the hosts glided straight at Russell as Rovers almost hit back only minutes after the hosts had taken the lead.
An eye-catching pass from Hughes was met by the on rushing Norwood, who dinked a shot when one-on-one with Hurst onto the bar, and the England C man couldn't put away the follow up header.
Rovers leading marksman tried his luck again minutes later but this time Hurst was able to foil his low effort from the edge of the box.
Then came the killer goal, the finest strike of the night, as O'Sullivan burst down the right to power a superb smash on goal past the reach of the diving Russell.
It was the gap in the score-line the hosts so desperately needed, as the conditions worsened even further, calling into question how realistically the game could continue with areas of the pitch fast becoming unplayable.
Referee Adrian Jones ploughed on however, and it was in fact the hosts who looked the more likely to score next, as Russell was called upon to turn away a strong drive from former Cheltenham Town man Scott Brown.
The state of the pitch had deteriorated excessively as the match reached its conclusion as only a couple of simple saves for Hurst from substitutes Yan Klukowski and Danny Wright kept him busy.
For Rovers though a first defeat in four matches keeps them firmly in mid-table ahead of another visit to a long term league rival, Woking, on Tuesday.
© Copyright 2001-2017 Newsquest Media Group


text:
Faculty of BioethicsThe Pontifical Athenaeum Regina Apostolorum has opened a
Faculty of Bioethics. This Faculty, the first to be created
in the world, offers the possibility of a solid and
profound academic preparation in the difficult field of Bioethics, in
three levels: Bachelor, Master and Doctorate. The courses will begin
next October 2001, with the first year of every level.The
Faculty of Bioethics aims:To form specialists in bioethics, capable of
competently addressing the numerous and difficult ethical problems that continually
crop up in the area of biomedical and biological sciences;
strongly underlining the dignity of the human person and defending
every human individual´s life from conception to natural death. Intended
for:All who are interested in themes such as bioethics, health
promotion, and defence of life. Young people, who want to
dedicate themselves professionally to bioethics. Doctors, nurses and other Health
workers. Priests, catechists and those dedicated to pastoral tasks and
committed to the proclamation of the "Gospel of Life". Lawyers,
philosophers, social communicators. Volunteers or professional people generously dedicated to
the service of those most in need: the poor, women
in difficulty, unborn or abandoned children, sick and handicapped persons,
the elderly
The reason of this Faculty:Bioethics, in recent
Athenaeum Regina Apostolorum
years, has become a genuine academic subject, branching into other
subjects and becoming a genuine profession. Academic degrees which guarantee
adequate expertise are more than ever necessary for those who
intend working in this area. Application fields: Bioethics committees in
clinics, hospitals, and biomedical and biological investigation centers. Universities and
High schools. Institutions dedicated to bioethics: centers and institutes, associations
and various groups. Institutions dedicated to study of marriage and
family. Service and Help organizations: Family consulting centres, natural family
planning centers, organizations for women in difficulty, and for carrying
pregnancy to completion. Organizations and movements that defend life and
promote "the culture of life." Ecclesiastical structures and institutions: commissions
of the national or regional bishops´ conferences, diocesan or parochial
commissions. Seminaries, theological faculties, institutes of religious sciences and other
institutions dedicated to the formation of future priests, men and
woman religious, consecrated persons, religion teachers, catechists and other pastoral
agents. Persons and groups who are directly active in public
life: Legislators, government health and education ministries, political parties or
movements. Encounters for reflection and formation: congresses, debates, conferences, round
table discussions, study seminars
. Social Communications Media.Who can register?: For
the bachelor´s course, all those persons who hold a certificate
that in their country is valid for university studies. For
the master´s course, all who have satisfactorily completed the bachelor
degree in Bioethics or in Theology. For the doctorate, all
those who have a master in bioethics degree, or a
master in Theology and an adequate preparation in Bioethics. *
Scientific Council: The Faculty counts with the help of a
prestigious international Scientific Council . * Master in Bioethics:The Faculty
also organizes a "Master in Bioethics" open to students coming
from other faculties or universities. For more information


text:
What I Love About Me: Paris
Nominees Jennifer Lawrence and Marion Cotillard are both current faces of Dior, so it's highly likely that they'll be dressed by the French house for the SAG Awards or the Oscars. This dramatic marigold gown was one of the highlights of Raf Simons' latest collection for Dior, and we'd love to see it walk down the red carpet.
This regal gold gown would be perfect for a Best Actress nominee.
Milan Fashion Week Fall 2013 Street Style


text:
Braves' win streak halted as game slips away late
After Uggla's homer gives Atlanta the lead, Gearrin gives it back to Mets
NEW YORK -- While rolling through their previous eight games in perfect fashion, the Braves had routinely erased late-inning deficits with timely home runs that at least blurred their concerns of working with an inexperienced and injury-depleted bullpen.
The stage was set for the Braves to follow this familiar script as they aimed to complete their third consecutive sweep on Sunday night. But after Dan Uggla did his part by foiling Shaun Marcum's dominant effort with a go-ahead two-run home run in the seventh inning, Cory Gearrin succumbed to the pressure during a three-run eighth that provided the Mets a 4-2 win at Citi Field.
"You come out of here feeling like you've got a chance to sweep them," Braves manager Fredi Gonzalez said. "We still won two out of three. But with the game of baseball, the feeling always is, 'What have you done for me lately?'"
As the Braves soaked in the reality of this disheartening loss, they bid adieu to the excitement that surrounded them while they had won each of the previous eight games. This one ugly inning reintroduced them to the reality that they no longer have the luxury of handing late-inning leads to Jonny Venters and Eric O'Flaherty, who both underwent season-ending elbow surgeries during the past two weeks.
"When you're trying to get six outs with a one-run lead, it's tough at times," Gonzalez said. "You make a mistake or something happens, it's tough. We just got two runs [in the seventh inning] and didn't add on. Now you've got to ask them to get six outs with a one-run lead. It's difficult no matter who you have out there."
With O'Flaherty and Venters out for the remainder of the season and Jordan Walden at least a few days away from returning from a shoulder injury, the Braves have provided more significant roles to Luis Avilan and Gearrin.
After throwing just one pitch to strand the runner he inherited from Julio Teheran in the seventh inning, Avilan was replaced by pinch-hitter Ramiro Pena, whose sacrifice-bunt attempt proved unsuccessful when the Mets beat a lumbering Gerald Laird to second base. This prompted the entry of Gearrin, who had allowed a run in just one of his previous 26 appearances this season.
But most of those appearances did not come amid the pressure that built as Justin Turner opened the decisive eighth inning with a single and advanced to third base on Lucas Duda's double. John Buck followed with a game-tying single. Gearrin then hit Mike Baxter with a pitch before allowing Ike Davis to enjoy a rare celebratory moment after lacing his go-ahead two-run single through the infield's right side.
"Anytime you have an opportunity to win a game, you want to win it, especially knowing [closer Craig Kimbrel] is right there," Gearrin said. "Our job is to get him the ball. I don't think it's any bigger deal or less of a deal because of the stuff that has happened with the bullpen. You just want to win games."
With what was just his third hit in his past 47 at-bats, Davis increased his batting average to .158 and at least quieted the talk of him being sent to the Minors. In addition, he produced yet another unexpected development on a night when Marcum did not assume the appearance of a pitcher who had not completed at least five innings in three of his previous five starts.
Marcum took advantage of Atlanta's maddening offense as he recorded a career-high 12 strikeouts and completed seven innings for the first time since June 14, 2012. The only two hits the crafty right-hander surrendered through the first six innings were tallied by Andrelton Simmons, who opened the game with a single and hustled his way to a double with two outs in the sixth.
"Marcum pretty much had our number all night," Uggla said.
Marcum had retired 14 of the previous 15 batters he had faced before Justin Upton began the seventh inning with an infield single. Two batters later, Uggla drilled a changeup deep into the second level of seats beyond the left-field wall. The veteran second baseman's 10th homer of the year provided a short-lived lead and the opportunity for Teheran to earn a win.
As he allowed one run and pitched around three walks in 6 2/3 innings, Teheran was nowhere near as sharp as he had been on Monday, when he had thrown a career-high 123 pitches and came within two outs of his notching a shutout against the Twins.
The three walks Teheran issued through the first three innings were one more than he had issued in his previous five starts combined. Still, his only costly mistake came when he surrendered a fourth-inning leadoff home run to Duda.
"I don't think he was as sharp as we have seen him," Gonzalez said. "But Gerald did a good job getting him through some of those innings. He scattered the ball around a little bit, but he left the game giving up just one run."
Mark Bowman is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.


text:
Zach Johnson asked his short-iron approach on the par-4 18th to "Do something right, baby." It did.
With just a hint of a draw, Johnson's shot landed to the right of the right-side pin and spun to 2 feet to set up a birdie Thursday that left him two strokes behind first-round leader Patrick Reed in the Humana Challenge in La Quinta.
Johnson finished with a 7-under 65, hitting all 14 fairways at La Quinta Country Club — the most-demanding driving layout in the three-course event. He hit 15 of 18 greens in regulation and had 27 putts in his bogey-free round.
Johnson has 11 PGA Tour victories. Dating to his rookie season in 2004, only Woods, Phil Mickelson and Vijay Singh have more.
"It means that I'm doing something right," said Johnson, the top-ranked player in the field at No. 6.
Reed had a 9-under 63 in perfect scoring and weather conditions. He ran off five straight birdies in the middle of his bogey-free round on PGA West's Arnold Palmer Private Course and tied his career low.
With wife Justine pregnant with their first child, her brother, Kessler Karain, is subbing as Reed's caddie. Justine has walked every hole with her husband this year and plans to rejoin him inside the ropes after the baby girl arrives this summer.
Ryan Palmer, Justin Hicks, Daniel Summerhays and Charley Hoffman shot 64.
Palmer birdied his final six holes and nine of his last 12 on the Palmer course, the site of the final round Sunday.
European Tour: Phil Mickelson didn't have much success with his new driver in the first round of the Abu Dhabi HSBC Golf Championship, failing to make a single birdie in a 1-over 73 to sit six shots behind the leaders. Mickelson made 17 straight pars in his first round of the year before a bogey on his last hole, joining a number of big names who struggled on the opening day in Abu Dhabi, United Arab Emirates.
"I can't recall the last time I had a round without a birdie," Mickelson said. "But didn't make a bogey there until the last."
Matthew Baldwin of England was tied for the lead with Romain Wattel of France and Rafa Cabrera-Bello after a 67. Seven players, including European Ryder Cup captain Paul McGinley, were one shot behind.
Mickelson's playing partner Rory McIlroy carded a 70 while Henrik Stenson had four bogeys in a 74. Mickelson only hit five of 14 fairways on the Peter Harradine-designed course. Sergio Garcia opened with 76.


text:
Bound To Please Spandex Hood
Sign In or Create Account to rate.
Brand: Good Vibrations Toys
Go deep undercover for your BDSM adventure with the Bound to Please Spandex Hood. Read More
Go deep undercover for your BDSM adventure with the Bound to Please Spandex Hood. This kinky handmade hood features a soft padded blindfold for comfort and a mouth opening for access and safety during your sensual sessions of bondage play. Made from spandex, the Bound to Please Hood offers a snug fit without snagging or feeling suffocating, and resists staining from lubes, oils and other fluids. Easy to care for and use, the Bound to Please Hood is a great addition to your bondage and fantasy play collection.
Bound To Please Spandex Hood
Black Spandex
Hand wash with mild soap
Stretchy material: one size fits many
Brand: Good Vibrations Toys
Material: Spandex
Color: Black
Dimensions: flat: 13" h x 9" w, 6.5" neck opening unstretched
- Machine Washable
- Stretchy
- Good first time hood
- Adjustable
Browse Similar
Reviews & RatingsRate and Review It
Sign In or Create Account to save favorites.
You have reached the favorite limit. You will need to delete some to save favorites.


text:
A night of playing video games turned deadly last year, according to a witness who testified in Solano County Superior Court on Friday about the night a woman was shot death in a Suisun City home.
Timothy Wallace took the witness stand in a probable-cause hearing for 33-year-old Ryan J. Moore, who is charged with the murder of Bettina Brown, 41. Moore has pleaded not guilty to one count of murder with an enhancement which alleges he personally used a firearm causing death.
On Friday, Wallace testified that Moore had called him over to his Stellar Way home on the evening of Oct. 23 to play a video game.
Once there, Wallace testified that Moore seemed sad over some text messages that he had received from his girlfriend, indicating they were breaking up. Moore then grabbed a bottle of tequila and drank from it "like water," Wallace testified.
Wallace then testified that he became nervous when Moore began playing with a butterfly knife, and told him to stop playing with it. Inside the living room, where they were going to play the video game, Brown was sitting nearby on a couch.
Police have previously said that Brown had been staying at the home, and Wallace testified that she was not dating Moore.
Brown told Wallace not to worry, saying he
wouldn't cut her.
Moore dropped the butterfly knife and got up as if he was going to the bathroom, instead picking up a rifle, Wallace testified.
Moore then said, "Well, then I'm going to shoot her," Wallace testified.
"I said put the gun down," Wallace added.
Then a shot rang out and Brown shot straight up out of her chair, according to Wallace.
Wallace testified that Moore then "jumped" on Brown and it appeared he was "holding her wound."
Scared, Wallace then ran for the door and ran the three blocks to his uncle's house, where he called police.
"I was scared for my life. I thought I might be shot," Wallace testified.
The hearing is set to continue at 11 a.m. on Monday in the Fairfield courtroom of Judge Wendy G. Getty.
Moore remains in Solano County Jail custody without bail.
Follow Staff Writer Ryan Chalk at Twitter.com/RyanChalk1883.


text:
Sign into our member site to view your information online.Forget your username or password? Not registered? Register here
triamcinolone injection (generic name)
Ken-Jec 40 (brand name)
It helps to reduce swelling, redness, itching, and allergic reactions
(trye am SIN oh lone)
Table of Contents
Top Learning Centers(Recursos en Español)
What is this medicine?TRIAMCINOLONE (trye am SIN oh lone) is a corticosteroid. It helps to reduce swelling, redness, itching, and allergic reactions. This medicine is used to treat allergies, arthritis, asthma, skin problems, and many other conditions.
What should I tell my health care provider before I take this medicine?They need to know if you have any of these conditions:
How should I use this medicine?This medicine is injected by a health care professional. After your dose follow your doctor's instructions for your care.
Contact your pediatrician regarding the use of this medicine in children. Special care may be needed.
What if I miss a dose?This does not apply.
What may interact with this medicine?Do not take this medicine with any of the following medications:
This medicine may also interact with the following medications:
What should I watch for while using this medicine?Visit your doctor or health care professional for regular checks on your progress. If you are diabetic, check your blood sugar as directed. If you are taking this medicine for a long time, carry an identification card with your name, the type and dose of medicine, and your doctor's name and address.
You may need to be on a special diet while taking this medicine. Talk to your doctor.
Do not come in contact with people who have chickenpox or the measles while you are taking this medicine. If you do, call your doctor right away.
What side effects may I notice from receiving this medicine?Side effects that you should report to your doctor or health care professional as soon as possible:
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
Where should I keep my medicine?Keep out of the reach of children.
Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F). Do not freeze. Protect from light. Throw away any unused medicine after the expiration date.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.


text:
Topic: A vitamin pill a day keeps cancer away? Unlikely
A vitamin pill a day keeps cancer away? Unlikely
http://scienceblog.cancerresearchuk.org … r-homepage
cholangiocarcinoma.org :: Cholangiocarcinoma Foundation Discussion Board
a resource for patients, friends, caregivers and loved ones.
You are not logged in. Please login or register.
|La fundación de colangiocarcinoma (CCF) ahora ofrece servicios de traducción en Español.
Por favor publique sus preguntas en Español y un intérprete le va responder.
Join our new Mentoring Program
A new discussion board experience is coming this September!
After 10 years, we're upgrading our discussion board to a new modern system. The new forum will be easier to use, mobile-friendly and loaded with new features! We'll be taking all of the existing posts and users over to the new board, you won't have to do anything. If you have any questions, we've started a thread here to discuss.
Cholangiocarcinoma Foundation Discussion Board → Websites → A vitamin pill a day keeps cancer away? Unlikely
A vitamin pill a day keeps cancer away? Unlikely
http://scienceblog.cancerresearchuk.org … r-homepage
Gav, it didn't work for Teddy and me! So, I finally gave up my pre-natals........LOL
Thanks, Gavin for posting this valuable link.
In regards to the study group (middle-aged or older men) I am irked by the fact that we continue to see an exclusion of the "female" population.
According to the published studies for 2011 there are 101.3 men to every 100 females in the world.
Hello, researchers, we are not to be overlooked.
Dear Marion, please don't be irked
The study in question was done at Harvard. It's part of their ongoing research called the Physicians' Health Study. Yes, it focuses on males.
Harvard runs a similar series of studies that includes only females. It's called the Nurses' Health Study.
I'm guessing Harvard researchers have some very good reasons to run these studies separately. Males and females have distinct health issues!!
Oh, Eli, I forgot about the Nurse's Health Study. Thanks for setting me straight.
Sorry, I owe an apology to all of you males. Forgiven?
BTW, I stopped taking multivitamin pills after my second resection in June 2010.
One reason is that ,most of them contain folic acid and if someone like me who is on capecitabine(Xeloda) or injectable like 5 FU, it may not be a good idea.
God bless.
Percy...my husband was given 5-FU plus leucovorin. This was almost six years ago. But the most current literature I found dispells the benefit- risk factor of the combination:
http://www.drugs.com/food-interactions/ … eloda.html
Eli...do you know whether this very same study is conducted on women also -Vitamins - Health benefits?
No, the very same study is not conducted on women.
Physicians' Health Study II was specifically designed to test common vitamins and multivitamins. It was randomized and placebo-controlled.
Nurses' Health Study is a much broader study. It looks at many different health issues. And it's not randomized. They ask nurses to fill in questionnaires on a regular basis.
That said....
Nurses' study did look at the multivitamins. I found the summary of their results in this article:
Do Multivitamins Make You Healthier?
http://www.wellsource.com/articles-mhc/ … thier.html
Here's the summary:
[Nurses' Health Study] found no significant health advantage to taking multivitamins, except for a slightly lower risk for colon cancer in women taking multivitamins for more than 15 years. (Some research shows folic acid to be protective against bowel cancer.) Researchers also found a slight increased risk for fatal non-Hodgkin's lymphoma in multivitamin users.
The article mentions another large study called The Women's Health Initiative. It too examined many different health issues. Here's their publication on multivitamins:
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts
Their conclusion:
After a median follow-up of 8.0 and 7.9 years in the clinical trial and observational study cohorts, respectively, the Women's Health Initiative study provided convincing evidence that multivitamin use has little or no influence on the risk of common cancers, CVD (cardio-vascular desease), or total mortality in postmenopausal women.
Thanks much, Eli. This is really interesting. Thanks again,
Glad that the link was of interest and use and thanks to you Eli for posting your other links too.
The information expressed is not medical advice. The discussion boards are not intended to replace the services of a trained health professional or to be a substitute for the medical advice of physicians or other healthcare providers. Read the full disclaimer.


text:
Groene at the Legislature: Teacher absences, substitutes
Mail: Southern statues symbolize suppression
More opinion
Senate: Vote no on Graham-Cassidy health care plan
Fall: Good time to spray musk thistle in rosette stage
More Ag News
Nebraska women will learn how to care and plan for their farms, communities, families and themselves at the 28th Women in Agriculture Conference, one of the longest-running women's conference of its kind, Feb. 21-22 at the Kearney Holiday Inn.
Grandin, a professor of animal science at Colorado State University, is a world leader in the design of livestock handling and cattle processing facilities. Her designs emphasize reducing animal stress. Grandin also consulted with such companies as McDonald's, Cargill and Tyson.
Along with her research in animal handling, Grandin has both written and spoken about her experience with autism, which she was diagnosed with as a child.
Other speakers include Jolene Brown, a farmer and author from West Branch, Iowa, and Cheryl Burkhart-Kriesel, co-owner of Kriesel Certified Seed and a University of Nebraska-Lincoln Extension community development specialist.
Brown will be the keynote speaker Thursday morning with her talk, "It's a Jungle Out There! Blazing New Trails for Agriculture."
Burkhart-Kriesel will speak on how to draw residents to rural Nebraska communities. Grandin will close the conference with her speech at noon Friday.
In between these lectures, conference-goers can choose from more than 30 workshops spread over five sessions during the event. Topics include livestock and grain marketing, crop insurance, family communication, business transition and beef nutrition.
R.P. Smith, a cowboy poet from Broken Bow, will entertain on Thursday evening, followed by "funshops," opportunities to network and socialize in a low-pressure setting.
Those interested can register online at wia.unl.edu. They can also register by calling 1-800-535-3456 or by faxing their form to 1-402-472-0776. Hard copy registration forms can be sent to Women in Agriculture, UNL Agricultural Economics, 303 Filley Hall, Lincoln, Neb., 68583.
The early-bird fee of $100 per person is due by Feb. 8. Following that date the fee is $120 per person. Fee includes workshop materials, registration and meals.
The conference is sponsored by the Institute of Agriculture and Natural Resources, University of Nebraska-Lincoln Extension and the Department of Agricultural Economics.
Lodging is available at the Kearney Holiday Inn, 110 2nd Ave., 308-237-5971.
For more information, visit wia.unl.edu.
Flatrock Publishing, Inc.
1300 E 4th St., Suite F
North Platte, NE 69101